Genetic Signatures Limited GSS.AX Stock
Genetic Signatures Limited Price Chart
Genetic Signatures Limited GSS.AX Financial and Trading Overview
| Genetic Signatures Limited stock price | 0.69 AUD |
| Previous Close | 0.53 AUD |
| Open | 0.53 AUD |
| Bid | 0.5 AUD x 0 |
| Ask | 0.53 AUD x 0 |
| Day's Range | 0.51 - 0.53 AUD |
| 52 Week Range | 0.5 - 1.33 AUD |
| Volume | 9.77K AUD |
| Avg. Volume | 79.9K AUD |
| Market Cap | 74.57M AUD |
| Beta (5Y Monthly) | 0.175478 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.12 AUD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 0.95 AUD |
GSS.AX Valuation Measures
| Enterprise Value | 52.74M AUD |
| Trailing P/E | N/A |
| Forward P/E | -7.428571 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 3.0583243 |
| Price/Book (mrq) | 1.5204678 |
| Enterprise Value/Revenue | 2.163 |
| Enterprise Value/EBITDA | -7.693 |
Trading Information
Genetic Signatures Limited Stock Price History
| Beta (5Y Monthly) | 0.175478 |
| 52-Week Change | -49.28% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.33 AUD |
| 52 Week Low | 0.5 AUD |
| 50-Day Moving Average | 0.68 AUD |
| 200-Day Moving Average | 0.8 AUD |
GSS.AX Share Statistics
| Avg. Volume (3 month) | 79.9K AUD |
| Avg. Daily Volume (10-Days) | 117.18K AUD |
| Shares Outstanding | 143.41M |
| Float | 129.35M |
| Short Ratio | N/A |
| % Held by Insiders | 35.41% |
| % Held by Institutions | 26.06% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | -33.29% |
| Operating Margin (ttm) | -33.45% |
| Gross Margin | 52.62% |
| EBITDA Margin | -28.11% |
Management Effectiveness
| Return on Assets (ttm) | -9.067% |
| Return on Equity (ttm) | -15.60% |
Income Statement
| Revenue (ttm) | 24.38M AUD |
| Revenue Per Share (ttm) | 0.17 AUD |
| Quarterly Revenue Growth (yoy) | -50.70% |
| Gross Profit (ttm) | 21.9M AUD |
| EBITDA | -6855000 AUD |
| Net Income Avi to Common (ttm) | -8118000 AUD |
| Diluted EPS (ttm) | -0.06 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 26.85M AUD |
| Total Cash Per Share (mrq) | 0.19 AUD |
| Total Debt (mrq) | 2K AUD |
| Total Debt/Equity (mrq) | 0.004 AUD |
| Current Ratio (mrq) | 9.335 |
| Book Value Per Share (mrq) | 0.342 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -3377000 AUD |
| Levered Free Cash Flow (ttm) | -7600000 AUD |
Profile of Genetic Signatures Limited
| Country | Australia |
| State | NSW |
| City | Newtown |
| Address | Heart Research Institute |
| ZIP | 2042 |
| Phone | 61 2 9870 7580 |
| Website | https://www.geneticsignatures.com |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Genetic Signatures Limited operates as a molecular diagnostic (MDx) company in Australia, the Asia Pacific, the Americas, Europe, the Middle East, Israel, and Africa. It designs and manufactures a suite of real-time polymerase chain reaction-based products for detection of infectious diseases under the EasyScreen brand name. The company also provides MDx 3Base platform technology that enables hospital and pathology laboratories to screen for a range of infectious pathogens. In addition, it offers detection kits for gastrointestinal infections, respiratory, sexual health, anti-microbial resistance, meningitis, and tropical disease. The company was incorporated in 2001 and is headquartered in Newtown, Australia.
Q&A For Genetic Signatures Limited Stock
What is a current GSS.AX stock price?
Genetic Signatures Limited GSS.AX stock price today per share is 0.69 AUD.
How to purchase Genetic Signatures Limited stock?
You can buy GSS.AX shares on the ASX exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Genetic Signatures Limited?
The stock symbol or ticker of Genetic Signatures Limited is GSS.AX.
Which industry does the Genetic Signatures Limited company belong to?
The Genetic Signatures Limited industry is Diagnostics & Research.
How many shares does Genetic Signatures Limited have in circulation?
The max supply of Genetic Signatures Limited shares is 186.48M.
What is Genetic Signatures Limited Price to Earnings Ratio (PE Ratio)?
Genetic Signatures Limited PE Ratio is now.
What was Genetic Signatures Limited earnings per share over the trailing 12 months (TTM)?
Genetic Signatures Limited EPS is -0.12 AUD over the trailing 12 months.
Which sector does the Genetic Signatures Limited company belong to?
The Genetic Signatures Limited sector is Healthcare.